Novel Cardiac Biomarker Predicts Progression of Heart Failure in Chronic HIV-Infected Patients by EON


SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the Presage® ST2 Assay, announced today that during a presentation at the American Heart Association Scientific Sessions in Los Angeles, the results of a study demonstrated that elevated levels of the biomarker ST2 in HIV patients was strongly indicative of the development of heart failure and mortality. The Joint United Nations Program UNAIDS estimates that there are now 33 million people living with HIV/AIDS worldwide. The Center for a style

More Info
To top